-
Study aim
-
Investigating the safety and efficacy of fractional microneedle Sophia device, manufacturde by Parnian Gostar Radiometer Company, in rejuvenating facial skin
-
Design
-
Single group, phase 2, before -after clinical study on 21 participants.
-
Settings and conduct
-
The study will be performed in Center for Research and Study in skin Diseases and Leprosy. 21 healthy volunteers will be selected and enrolled in the study after signing consent form. Four treatment sessions will be performed using fractional microneedle Sophia device, manufactured by Parnian Gostar Radiometer Company. Skin photography and measurement of skin biophysical parameters (including skin elasticity, area and volume of wrinkles as well as ultrasound parameters) will be performed before treatment, as well as 4 and 8 weeks later.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Ages 30 to 60, People with facial skin wrinkles grade 2 and 3 based on Glogau scale and mild to moderate sagging (1 and 2) based on the Modified Fitzpatrick wrinkle criteria, Signing the consent form for participation in the study
Exclusion criteria:
History of using any type of device filler, including silicone, fat, collagen, hyaluronic acid or artificial materials in the treatment area, History of any type of cosmetic surgery during the last 3 years at the treatment area, Use of Isotretinoin in the last 6 months
-
Intervention groups
-
4 sessions of full face treatment with fractional microneedle Sophia device, manufacturde by Parnian Gostar Radiometer Company as a complete pass on full face. The diameter of the needles in this system is equal to 120μm.
-
Main outcome variables
-
Facial skin wrinkle grading, using Glogau scale